According to the report published by the Market Research Store, global demand for the Adenovir diagnostic market was estimated at approximately USD 2,560.1 Million in 2020 and is expected to generate revenue of around USD 3,911.8 Million by end of 2026, growing at a CAGR of around 11.5% between 2021 and 2026.

Global Adenovir Diagnostic Market: Overview

Adenovirus is one of the DNA viruses that are considered to be the major cause of fever illnesses that is found mostly among children.  Adenovirus infections can be recognized by polymerase chain reaction (PCR), antigen detection, virus isolation, and serology and its typing is generally done by molecular methods. Even if any individual has got symptoms of adenovirus infection, it does not necessarily indicate it is causing the individual's specific illness. Sometimes, most of the infections caused by adenovirus are not too critical.

In addition, individuals and children with weak immune systems, chronic respiratory difficulties, and cardiac disease are at higher risk of contracting adenovirus infection. Adenovirus causes various disorders like pneumonia, gastroenteritis, acute respiratory disease, epidemic keratoconjunctivitis, cystitis, and acute follicular conjunctivitis. Moreover, this contagious disease is an airborne disease spreading from an infected person to others through cough, sneezing or close contact. Pharyngitis fever and pharyngeal-conjunctival are the most common disease caused by adenovirus among children. In 2016, according to the Barcelona Center for International Health Research and the University of Barcelona specified that adenovirus is the second most common respiratory virus that causes pneumonia. Adenovirus can also spread through the infected person’s stool or from swimming pools. Technological development such as chromatography, liposome, flow cytometry, gel microdroplets, and monoclonal antibodies are rising as the method of option for the identification of adenovirus infection.

REPORT SNAPSHOT & REPORTING DATA TIMEFRAME
Parameter Details
Historical Date ( Actual Data) 2016 - 2020
Base Year Data 2020
Current Year Data 2021
Projected Data 2021 - 2026
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered product type, application, region
Regional scope North America; Europe; Asia Pacific; Central & South America; Middle East & Africa
Country Scope U.S.; Canada; Mexico; Germany; France; U.K.; China; Japan; South Korea; Singapore; Malaysia; Brazil; Saudi Arabia
Customization scope Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Adenovir Diagnostic Market: Growth Factor

Confirmation of the adenovirus infection is essential to recognize the most appropriate treatment in order to begin the treatment method to bring the control of infection by the use of an accurate antiviral agent which is projected to drive the growth of the market of global adenovirus diagnostics. Earlier, due to the competent replication of the virus in cell cultures, the adenovirus infections were diagnosed by cell culture.

By means of different PCR techniques, amplification and detection of adenovirus DNA are usually done in lab procedures for the identification of adenovirus infection. Furthermore, rising investments in research and development and industrial advancement in the diagnosis of acute respiratory infection of viral diagnosis are anticipated to stimulate the growth in the adenovirus diagnostics market. The rapid detection and quantization of adenovirus DNA, using specific techniques such as PCR is likely to drive the growth of the global adenovirus diagnostic market in the upcoming years.

Global Adenovir Diagnostic Market: Segmentation

The global adenovirus diagnostics market is classified into diagnostic methods and end-user. Depending upon diagnostic method, the industry is segmented into polymerase chain reaction assays, viral culture, monoclonal antibodies, liposome and flow cytometry, chromatography, and gel microdroplets. On the basis of the end-user industry, the market for global adenovirus diagnostics is categorized as private diagnostic laboratories, hospitals, public health laboratories, and small clinics.

Global Adenovir Diagnostic Market: Regional Analysis

North America is projected to expand major traction due to the rise in public health concerns about the various infectious disorders such as pneumonia that is related to adenovirus infection and reimbursement for adenovirus diagnostics. Furthermore, several hospitals, clinics, and private diagnostics laboratories in the U.S. and Canada offer an expansive portfolio of tests for the detection of adenovirus. The adenovirus diagnostic market in Europe is accounted for the largest share market across the globe. The Asia Pacific is also anticipated to develop at a rapid rate owing to the rise in occurrence of the infection. The adenovirus diagnostic market is likely to grow in Africa, where a huge number of children infected with adenovirus are neglected.

Global Adenovir Diagnostic Market: Competitive Players

The major manufacturers in the global adenovirus diagnostics market cover Qiagen, Becton, Dickinson and Company,  Agilent Technologies, Affymetrix, Roche, Novartis AG, Abbott, DiaSorin, BioMerieux, Gen-Probe, Bio-Rad, and Beckman Coulter/Danaher.

For example, in March 2021, QIAGEN received FDA emergency use of authorization for NeuMoDx Multiplex Test expanding the Covid-19 portfolio.

Global Adenovir Diagnostic Market: By Diagnostic Method

  • Viral Culture
  •  Polymerase Chain Reaction Assays
  •  Monoclonal Antibodies
  •  Liposome and Flow Cytometry
  •  Chromatography
  •  Gel Micro Droplets

Global Adenovir Diagnostic Market: By End-User

  • Hospitals
  • Private Diagnostic Laboratories
  • Small Clinics
  • Public Health Laboratories

Global Adenovir Diagnostic Market: Regional Segmentation Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

Frequently Asked Questions

What are the key factors driving Adenovir Diagnostic market expansion?

Confirmation of the adenovirus infection is essential to recognize the most appropriate treatment in order to begin the treatment method to bring the control of infection by the use of accurate antiviral agent which is projected to drive the growth of the market of global adenovirus diagnostics. Furthermore, rising investments in research and development and industrial advancement in the diagnosis of acute respiratory infection of viral diagnosis are anticipated to stimulate the growth in adenovirus diagnostics market.

What will be the value of Adenovir Diagnostic market during 2021 - 2026?

The global demand for the Adenovir diagnostic market was estimated at approximately USD 2,560.1 Million in 2020 and is expected to generate revenue of around USD 3,911.8 Million by end of 2026, growing at a CAGR of around 11.5% between 2021 and 2026.

Which region will make notable contributions towards global Adenovir diagnostic market revenue?

North America is projected to expand major traction due to rise in public health concerns about the various infectious disorders such as pneumonia that is related to adenovirus infection and reimbursement for adenovirus diagnostics.

What are the key players leveraging Adenovir diagnostic market growth?

The major manufacturers in the global adenovirus diagnostics market covers Qiagen, Becton, Dickinson and Company,  Agilent Technologies, Affymetrix, Roche, Novartis AG, Abbott, DiaSorin, BioMerieux, Gen-Probe, Bio-Rad, and Beckman Coulter/Danaher.

 

Table Of Content

  • Chapter 1 Executive Summary
    • 1.1. Introduction of Adenovir diagnostic
    • 1.2. Global Adenovir diagnostic Market, 2020 & 2026 (USD Million)
    • 1.3. Global Adenovir diagnostic Market, 2016 – 2026(USD Million)
    • 1.4. Global Adenovir diagnostic MarketAbsulute Revenue Opportunity, 2016 – 2026(USD Million)
    • 1.5. Global Adenovir diagnostic MarketIncremental Revenue Opportunity, 2020 – 2026(USD Million)
  • Chapter 2 Adenovir diagnostic Market – Diagnostic Method Analysis
    • 2.1. Global Adenovir diagnostic Market – Diagnostic Method Overview
    • 2.2. Global Adenovir diagnostic Market Share, by Diagnostic Method , 2020 & 2026(USD Million)
    • 2.3. Viral Culture
      • 2.3.1. Global Viral CultureAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 2.4. Pulymerase Chain Reaction Assays and Antigen-Based Assays
      • 2.4.1. Global Pulymerase Chain Reaction Assays and Antigen-Based AssaysAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 2.5. Monoclonal Antibodies
      • 2.5.1. Global Monoclonal AntibodiesAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 2.6. Liposome
      • 2.6.1. Global LiposomeAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 2.7. Flow Cytometry
      • 2.7.1. Global Flow CytometryAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 2.8. Chromatography
      • 2.8.1. Global Chromatography Adenovir diagnostic Market, 2016 – 2026(USD Million)
    • 2.9. Gel Micro Droplets
      • 2.9.1. Global Gel Micro DropletsAdenovir diagnostic Market, 2016 – 2026(USD Million)
  • Chapter 3 Adenovir diagnostic Market – End User Analysis
    • 3.1. Global Adenovir diagnostic Market – End User Overview
    • 3.2. Global Adenovir diagnostic Market Share, by End User, 2020 & 2026(USD Million)
    • 3.3. Hospitals
      • 3.3.1. Global HospitalsAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 3.4. Private Diagnostic Laboratories
      • 3.4.1. Global Private Diagnostic LaboratoriesAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 3.5. Small Clinics
      • 3.5.1. Global Small ClinicsAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 3.6. Public Health Laboratories
      • 3.6.1. Global Public Health LaboratoriesAdenovir diagnostic Market, 2016 – 2026(USD Million)
  • Chapter 4 Adenovir diagnostic Market – Regional Analysis
    • 4.1. Global Adenovir diagnostic Market Regional Overview
    • 4.2. Global Adenovir diagnostic Market Share, by Region, 2020 & 2026(USD Million)
    • 4.3. North America
      • 4.3.1. North AmericaAdenovir diagnostic Market, 2016 – 2026(USD Million)
        • 4.3.1.1. North AmericaAdenovir diagnostic Market, by Country, 2016 - 2026(USD Million)
      • 4.3.2. North AmericaAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026
        • 4.3.2.1. North AmericaAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026(USD Million)
      • 4.3.3. North AmericaAdenovir diagnostic Market, by End User, 2016 – 2026
        • 4.3.3.1. North AmericaAdenovir diagnostic Market, by End User, 2016 – 2026(USD Million)
      • 4.3.4. U.S.
        • 4.3.4.1. U.S.Adenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.3.5. Canada
        • 4.3.5.1. CanadaAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 4.4. Europe
      • 4.4.1. EuropeAdenovir diagnostic Market, 2016 – 2026(USD Million)
        • 4.4.1.1. EuropeAdenovir diagnostic Market, by Country, 2016 - 2026(USD Million)
      • 4.4.2. EuropeAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026
        • 4.4.2.1. EuropeAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026(USD Million)
      • 4.4.3. EuropeAdenovir diagnostic Market, by End User, 2016 – 2026
        • 4.4.3.1. EuropeAdenovir diagnostic Market, by End User, 2016 – 2026(USD Million)
      • 4.4.4. Germany
        • 4.4.4.1. GermanyAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.4.5. France
        • 4.4.5.1. FranceAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.4.6. U.K.
        • 4.4.6.1. U.K.Adenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.4.7. Italy
        • 4.4.7.1. ItalyAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.4.8. Spain
        • 4.4.8.1. SpainAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.4.9. Rest of Europe
        • 4.4.9.1. Rest of EuropeAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 4.5. Asia Pacific
      • 4.5.1. Asia PacificAdenovir diagnostic Market, 2016 – 2026(USD Million)
        • 4.5.1.1. Asia PacificAdenovir diagnostic Market, by Country, 2016 - 2026(USD Million)
      • 4.5.2. Asia PacificAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026
        • 4.5.2.1. Asia PacificAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026(USD Million)
      • 4.5.3. Asia PacificAdenovir diagnostic Market, by End User, 2016 – 2026
        • 4.5.3.1. Asia PacificAdenovir diagnostic Market, by End User, 2016 – 2026(USD Million)
      • 4.5.4. China
        • 4.5.4.1. ChinaAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.5.5. Japan
        • 4.5.5.1. JapanAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.5.6. India
        • 4.5.6.1. IndiaAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.5.7. South Korea
        • 4.5.7.1. South KoreaAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.5.8. South-East Asia
        • 4.5.8.1. South-East AsiaAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.5.9. Rest of Asia Pacific
        • 4.5.9.1. Rest of Asia PacificAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 4.6. Latin America
      • 4.6.1. Latin AmericaAdenovir diagnostic Market, 2016 – 2026(USD Million)
        • 4.6.1.1. Latin AmericaAdenovir diagnostic Market, by Country, 2016 - 2026(USD Million)
      • 4.6.2. Latin AmericaAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026
        • 4.6.2.1. Latin AmericaAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026(USD Million)
      • 4.6.3. Latin AmericaAdenovir diagnostic Market, by End User, 2016 – 2026
        • 4.6.3.1. Latin AmericaAdenovir diagnostic Market, by End User, 2016 – 2026(USD Million)
      • 4.6.4. Brazil
        • 4.6.4.1. BrazilAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.6.5. Mexico
        • 4.6.5.1. MexicoAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.6.6. Rest of Latin America
        • 4.6.6.1. Rest of Latin AmericaAdenovir diagnostic Market, 2016 – 2026(USD Million)
    • 4.7. The Middle-East and Africa
      • 4.7.1. The Middle-East and AfricaAdenovir diagnostic Market, 2016 – 2026(USD Million)
        • 4.7.1.1. The Middle-East and AfricaAdenovir diagnostic Market, by Country, 2016 - 2026(USD Million)
      • 4.7.2. The Middle-East and AfricaAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026
        • 4.7.2.1. The Middle-East and AfricaAdenovir diagnostic Market, by Diagnostic Method , 2016 – 2026(USD Million)
      • 4.7.3. The Middle-East and AfricaAdenovir diagnostic Market, by End User, 2016 – 2026
        • 4.7.3.1. The Middle-East and AfricaAdenovir diagnostic Market, by End User, 2016 – 2026(USD Million)
      • 4.7.4. GCC Countries
        • 4.7.4.1. GCC CountriesAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.7.5. South Africa
        • 4.7.5.1. South AfricaAdenovir diagnostic Market, 2016 – 2026(USD Million)
      • 4.7.6. Rest of Middle-East Africa
        • 4.7.6.1. Rest of Middle-East AfricaAdenovir diagnostic Market, 2016 – 2026(USD Million)
  • Chapter 5 Adenovir diagnostic Market – Competitive Landscape
    • 5.1. Competitor Market Share – Revenue
    • 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    • 5.3. Strategic Developments
      • 5.3.1. Acquisitions and Mergers
      • 5.3.2. New Products
      • 5.3.3. Research & Development Activities
  • Chapter 6 Company Profiles
    • 6.1. Agilent Technulogies
      • 6.1.1. Company Overview
      • 6.1.2. Product/ServicePortfulio
      • 6.1.3. Agilent Technulogies Sales, Revenue, and Gross Margin
      • 6.1.4. Agilent Technulogies Revenue and Growth Rate
      • 6.1.5. Agilent Technulogies Market Share
      • 6.1.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.2. Beckman Coulter/Danaher
      • 6.2.1. Company Overview
      • 6.2.2. Product/ServicePortfulio
      • 6.2.3. Beckman Coulter/Danaher Sales, Revenue, and Gross Margin
      • 6.2.4. Beckman Coulter/Danaher Revenue and Growth Rate
      • 6.2.5. Beckman Coulter/Danaher Market Share
      • 6.2.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.3. Becton
      • 6.3.1. Company Overview
      • 6.3.2. Product/ServicePortfulio
      • 6.3.3. Becton Sales, Revenue, and Gross Margin
      • 6.3.4. Becton Revenue and Growth Rate
      • 6.3.5. Becton Market Share
      • 6.3.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.4. Dickinson and Company
      • 6.4.1. Company Overview
      • 6.4.2. Product/ServicePortfulio
      • 6.4.3. Dickinson and Company Sales, Revenue, and Gross Margin
      • 6.4.4. Dickinson and Company Revenue and Growth Rate
      • 6.4.5. Dickinson and Company Market Share
      • 6.4.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.5. Affymetrix
      • 6.5.1. Company Overview
      • 6.5.2. Product/ServicePortfulio
      • 6.5.3. Affymetrix Sales, Revenue, and Gross Margin
      • 6.5.4. Affymetrix Revenue and Growth Rate
      • 6.5.5. Affymetrix Market Share
      • 6.5.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.6. Bio-Rad
      • 6.6.1. Company Overview
      • 6.6.2. Product/ServicePortfulio
      • 6.6.3. Bio-Rad Sales, Revenue, and Gross Margin
      • 6.6.4. Bio-Rad Revenue and Growth Rate
      • 6.6.5. Bio-Rad Market Share
      • 6.6.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.7. Roche
      • 6.7.1. Company Overview
      • 6.7.2. Product/ServicePortfulio
      • 6.7.3. Roche Sales, Revenue, and Gross Margin
      • 6.7.4. Roche Revenue and Growth Rate
      • 6.7.5. Roche Market Share
      • 6.7.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.8. Novartis AG
      • 6.8.1. Company Overview
      • 6.8.2. Product/ServicePortfulio
      • 6.8.3. Novartis AG Sales, Revenue, and Gross Margin
      • 6.8.4. Novartis AG Revenue and Growth Rate
      • 6.8.5. Novartis AG Market Share
      • 6.8.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.9. Gen-Probe
      • 6.9.1. Company Overview
      • 6.9.2. Product/ServicePortfulio
      • 6.9.3. Gen-Probe Sales, Revenue, and Gross Margin
      • 6.9.4. Gen-Probe Revenue and Growth Rate
      • 6.9.5. Gen-Probe Market Share
      • 6.9.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.10. Qiagen
      • 6.10.1. Company Overview
      • 6.10.2. Product/ServicePortfulio
      • 6.10.3. Qiagen Sales, Revenue, and Gross Margin
      • 6.10.4. Qiagen Revenue and Growth Rate
      • 6.10.5. Qiagen Market Share
      • 6.10.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.11. Abbott
      • 6.11.1. Company Overview
      • 6.11.2. Product/ServicePortfulio
      • 6.11.3. Abbott Sales, Revenue, and Gross Margin
      • 6.11.4. Abbott Revenue and Growth Rate
      • 6.11.5. Abbott Market Share
      • 6.11.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.12. DiaSorin
      • 6.12.1. Company Overview
      • 6.12.2. Product/ServicePortfulio
      • 6.12.3. DiaSorin Sales, Revenue, and Gross Margin
      • 6.12.4. DiaSorin Revenue and Growth Rate
      • 6.12.5. DiaSorin Market Share
      • 6.12.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
    • 6.13. and bioMerieux
      • 6.13.1. Company Overview
      • 6.13.2. Product/ServicePortfulio
      • 6.13.3. and bioMerieux Sales, Revenue, and Gross Margin
      • 6.13.4. and bioMerieux Revenue and Growth Rate
      • 6.13.5. and bioMerieux Market Share
      • 6.13.6. Recent Initiatives, Funding/VC Activities, and Technulogical Innovations
  • Chapter 7 Adenovir diagnostic — Industry Analysis
    • 7.1. Introduction and Taxonomy
    • 7.2. Adenovir diagnostic Market – Key Trends
      • 7.2.1. Market Drivers
      • 7.2.2. Market Restraints
      • 7.2.3. Market Opportunities
    • 7.3. Value Chain Analysis
    • 7.4. Key Mandates and Regulations
    • 7.5. Technulogy Roadmap and Timeline
    • 7.6. Adenovir diagnostic Market – Attractiveness Analysis
      • 7.6.1. By Diagnostic Method
      • 7.6.2. By End User
      • 7.6.3. By Region
  • Chapter 8 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    • 8.1. Adenovir diagnostic Industrial Chain Analysis
    • 8.2. Downstream Buyers
    • 8.3. Distributors/Traders List
  • Chapter 9 Marketing Strategy Analysis
    • 9.1. Marketing Channel
    • 9.2. Direct Marketing
    • 9.3. Indirect Marketing
    • 9.4. Marketing Channel Development Trends
    • 9.5. Economic/Pulitical Environmental Change
  • Chapter 10 Report Conclusion& Key Insights
    • 10.1. Key Insights from Primary Interviews & Surveys Respondents
    • 10.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  • Chapter 11 Research Approach & Methodulogy
    • 11.1. Report Description
    • 11.2. Research Scope
    • 11.3. Research Methodulogy
      • 11.3.1. Secondary Research
      • 11.3.2. Primary Research
      • 11.3.3. Statistical Models
        • 11.3.3.1. Company Share Analysis Model
        • 11.3.3.2. Revenue Based Modeling
      • 11.3.4. Research Limitations

Inquiry For Buying

Adenovir Diagnostic

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

Adenovir Diagnostic

Please fill out the form. We will contact you within 24 hours:
All fields required...
Inquiry For Buying

×

Avail Free PDF Sample Report

This website is secure and your personal details are safe. Privacy Policy

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com